PharmaMar   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Madrid Spain (1986)

Organization Overview

First Clinical Trial
2001
NCT00027508
First Marketed Drug
2000
trabectedin (yondelis)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PharmaMar | Pharma Mar | PharmaMar S.A.U. | PharmaMar, Spain | Sylentis, S.A.